Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Act to Improve Chronic Wounds in Alberta: Pivotal Study on the Use of NanoSALV Antimicrobial Wound Dressing to Treat Chronic Wounds

NCT05619237 is registered in ClinicalTrials.gov with Chester Ho, MD as lead sponsor.

NCT NCT05619237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05619237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Act to Improve Chronic Wounds in Alberta: Pivotal Study on the Use of NanoSALV Antimicrobial Wound Dressing to Treat Chronic Wounds
Lead sponsor
Chester Ho, MD
Phase
Not applicable
Overall status
Completed
Start date
December 6, 2022
Completion date
May 30, 2023
Enrollment
44 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer, leg ulcer, pressure injury, pressure injury stage 2, pressure injury stage iii, pressure injury stage iv, venous leg ulcer